In this cross-sectional analysis, we demonstrate a high prevalence of musculoskeletal US abnormalities (especially SGS) in the setting of established RA remission, regardless of whether this is defined by DAS28-CRP or ACR/EULAR Boolean criteria. This evidence concerns the gene CRP and rheumatoid arthritis.